Immunogenicity of third dose COVID-19 vaccine strategies in patients who are immunocompromised with suboptimal immunity following two doses (OCTAVE-DUO): an open-label, multicentre, randomised, controlled, phase 3 trial

Author:

Goodyear Carl S,Patel Amit,Barnes Eleanor,Willicombe Michelle,Siebert Stefan,de Silva Thushan I,Snowden John A,Lim Sean H,Bowden Sarah J,Billingham Lucinda,Richter Alex,Carroll Miles,Carr Edward J,Beale Rupert,Rea Daniel,Parry Helen,Pirrie Sarah,Lim Zixiang,Satsangi Jack,Dunachie Susanna J,Cook Gordon,Miller Paul,Basu Neil,Gilmour Ashley,Hodgkins Anne-Marie,Evans Lili,Hughes Ana,Longet Stephanie,Meacham Georgina,Yong Kwee L,A'Hearne Matthew J,Koh Mickey B C,Burns Siobhan O,Orchard Kim,Paterson Caron,McIlroy Graham,Murray Sam M,Thomson Tina,Dimitriadis Stavros,Goulston Lyndsey,Miller Samantha,Keillor Victoria,Prendecki Maria,Thomas David,Kirkham Amanda,McInnes Iain B,Kearns Pamela,Beesley Richard,Churchill Vicky,Insch Elspeth,Loughton Holly,MacDonald Eilean,Lax Siân,Lowe Faye,Magwaro Sophia,Gradwell Mark,Kinsella Francesca,Rolfe Hayley,McIntyre Stacey,Mortimer Paige,Al-Taei Saly,Tadros Susan,Workman Sarita,Arnott Maxine,Brock James,Melville Andrew,Najm Aurelie,Rutherford Matthew,Sunzini Flavia,Herman Lou S,Hobbs Agnieszka,Ragno Martina,Wu Mary Y,Selby Rachael,Clay Jennifer,Hutchison Clare,Lown Robert,Lwin May N,Meardon Naomi,Kelleher Peter,Lightstone Liz,Walters Thomas,Denyer Jayne,Ibrahim Rahima,Gleeson Sarah,Martin Paul,McAdoo Stephen,Baker Helena,Horswill Sarah,Parungao Nina,Saich Stephen,Cullinane James,Irwin Sophie,Klenerman Paul,Marjot Thomas,Chakraverty Ronjon,Holroyd Christopher,Kavi Janki,Trown Doreen,Babbage Gavin,Chackathayil Julia,Faria Patricia,Ingham Karen,Miah Murad,Miranda Mauro,O'Reilly Nicola,Smith Callie,Driver Kimberley,Gauntlett Kaylee,Farthing Andrew,Rundell Suzann,Smith Emily,Tong Andrew,Woolcock Kieran,Hanke Daniel,Laidlaw Stephen,Malik Zainab,Nguyen Dung,Provine Nicholas,Tipton Tom,Walker Victoria

Funder

UKRI Medical Research Council

Cancer Research UK

Blood Cancer UK

Publisher

Elsevier BV

Cited by 1 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3